MarketPulse

product revenue

4 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Axsome Therapeutics Eyes Investor Spotlight with Back-to-Back Healthcare Conferences

Axsome Therapeutics to present at BofA Securities and RBC Capital Markets healthcare conferences in May 2026, with webcast access for remote investors.
AXSMFDA approvalinvestor conference
GlobeNewswire Inc.GlobeNewswire Inc.··Autolus Therapeutics Plc

Autolus Therapeutics Posts $74.3M Revenue as AUCATZYL Scales Across Europe

Autolus Therapeutics reported $74.3M in 2025 AUCATZYL revenue with UK launch underway. Company projects $120-135M in 2026 revenue and positive gross margin expansion.
AUTLFDA approvalclinical trials
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Geron Posts $184M in Annual RYTELO Revenue, Guides 2026 Sales Growth

Geron's RYTELO generated $184M in 2025 revenue. The company guides 2026 sales of $220-240M, driven by domestic expansion and international opportunities.
GERNfinancial resultsFDA approval
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Autolus to Present Pipeline Updates at Spring Healthcare Conferences

Autolus to present pipeline updates and 2025 financial results at two March 2026 healthcare conferences, discussing commercial progress and strategic priorities.
AUTLinvestor conferencebiopharmaceutical